Manufacturing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

While allogeneic therapies can use existing regulatory and quality frameworks, autologous treatments will require pharma’s adoption of true just-in-time and right-first-time concepts, says consultant James Blackwell.


Reinterpreting Benchmarks for Innovative Therapies

The $21.4-billion acquisition will create stand-alone business within Danaher’s life-sciences portfolio.

Danaher to Acquire GE’s Biopharma Business

Mustang intends to combine an oncolytic virus with an interleukin-13 Rα2-(IL13Rα2)-specific chimeric antigen receptor to potentially enhance efficacy in treating glioblastoma multiforme.

Mustang Bio, Nationwide Children’s Hospital Sign License Agreement for Oncolytic Virus Therapy

Teva will apply Insilico’s technology for predictive biomanufacturing to create more efficient biomanufacturing processes.

Teva, Insilico Partner on Predictive Biomanufacturing Technology

Jennifer Markarian is a contributing editor for 

Suppliers address complex supply chains for global biopharmaceutical manufacturing using disposable components.

Challenges for Supplying Single-Use Systems

The company will invest an additional $60 million to expand its manufacturing facility in Durham County, NC.

Novartis’ AveXis to Expand Gene Therapy Manufacturing in North Carolina

Ireland’s National Institute for Bioprocessing Research and Training received funding from the Science Foundation Ireland’s Technology Innovation Development Award program for monoclonal antibody research.

NIBRT Secures Funding for mAb Research

The companies will jointly develop and commercialize an investigational bifunctional fusion protein immunotherapy currently in clinical development for cancer treatment.

GSK, Merck KGaA Partner in $4.2-Billion Cancer Immunotherapy Deal

In a deal potentially worth up to $460 million, Genentech and Xencor will develop and commercialize novel cytokine therapeutics.

Genentech, Xencor Partner on Cytokine Therapeutics

The acquisition will boost Hitachi Chemical’s presence in the European regenerative medicines market.

Manufacturing, Biologic Drugs